We Celebrate TEN Years of Excellence, LPBI Group: 4/2012 – 4/2022 | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

The Founder is a UC, Berkeley PhD’83 who had worked at Director Level for SRI Int’l, MITRE, PSC, McGraw Hill. Other employer organizations includes: Monitor Company (now Deloitte), Amdahl Corporation (now Fujitsu), PSC (now Dell Technologies). Positions in Healthcare are described in this link: http://Scientific and Medical Affairs Chronological CV

Aviva Lev-Ari, PhD, RN

Director & Founder

https://lnkd.in/eEyn69r

Picture date: 2/6/2022

While you are reviewing LPBI Group’s Portfolio of IP assets

https://pharmaceuticalintelligence.com/portfolio-of-ip-assets/

you will note that LPBI Group is venturing into Scientific NFT Marketplaces

https://pharmaceuticalintelligence.com/nft-redefined-format-of-ip-assets/

We plan to MINT as NFTs several of LPBI Group’s IP Asset Classes, such as

Curations among our +6,100 Journal articles – IP Asset Class I
eTOCs – Electronic Table of Contents of our 18 Books – IP Asset Class II
Gallery of +6200 Biological Images embedded in our Journal articles – IP Asset Class V
E-Proceedings of +100 Medical and Biotech Conferences we had covered in Real Time, 2013 – 2022 – IP Asset Class III
Tweet Collections of the latest 40 Medical and Biotech Conferences we had covered in Real Time, 2013 – 2022 – IP Asset Class III

Examples:

Tweet Collection of 2022 #EmTechDigital @MIT, March 29-30, 2022

https://pharmaceuticalintelligence.com/2022/04/02/tweet-collection-of-2022-emtechdigital-mit-march-29-30-2022/

Analytics for @AVIVA1950 Tweeting at #EmTechDigital

https://pharmaceuticalintelligence.com/2022/04/11/analytics-for-aviva1950-tweeting-at-emtechdigital/

Review our Testimonials

https://pharmaceuticalintelligence.com/praising-lpbi/

Our PAST is here

https://pharmaceuticalintelligence.com/home-website-front-page/

https://pharmaceuticalintelligence.com/2019-vista/

Our FUTURE is here

https://pharmaceuticalintelligence.com/vision/

https://pharmaceuticalintelligence.com/blockchain-transactions-network/

https://pharmaceuticalintelligence.com/synthetic-biology-in-drug-discovery/

https://pharmaceuticalintelligence.com/2021-medical-text-analysis-nlp/

https://pharmaceuticalintelligence.com/2021/07/24/proposal-for-new-e-book-architecture-combining-a-bi-lingual-etocs-english-spanish-with-nlps-results-of-medical-text-analysis-series-b-genomics-volume-1-2-and-series-c-cancer-volume-1/

Podcast of our Leaders are here

https://pharmaceuticalintelligence.com/audio-podcasts/

A stream of Ten INNOVATIONS in the Life of LPBI since

inception in 2012 to 2022

4/2012 – LPBI was the Launcher of a novel Scientific Curation Methodology for scientific findings in published primary research in the Global e-Scientific Publishing industry https://pharmaceuticalintelligence.com/
As late as 2016, no big publisher, not even one, i.e., Elsevier, John Wiley had curation-based publications: Journals, Books, e-Proceedings or Gallery of thousands of Biological Images as an IP asset class
At LPBI, Curation of scientific findings was performed in +6,000 articles with +2MM e-Views by Global e-Readers
6/2013 – LPBI was the Publisher of the 1^ste-book in Medicine in Kindle Store on the Life Sciences & Medicine Shelf – Upload to this shelf by Amazon.com
2/2021 – Completion of the 18 volumes, BioMed e-Series in five Specialties in Medicine: each article in each volume is a curation-based publication.
On Amazon.com on 7/2021 – LPBI’s e-books in Medicine enjoy +128,100 PAGE DOWNLOADS – the ONE and ONLY publisher in that range of page downloads. The record is the equivalent of 64 books at an average of 2,000 pages a volume !!!! LPBI smallest book is 1,000 pages and its biggest is +3,700 pages
LPBI launched its Natural Language Processing (NLP) Practice in 1/2020 as Mission #1. NLP is one method of Machine Learning (ML). ML is a family of methods in Artificial Intelligence (AI) which is a field in the Computer Science Academic discipline since the early 60s.
In 4/2021 Linguamatics/IQVIA performed NLP on LPBI’s 33 articles and 20 Biological Images. RESULTS: +670 entity relations DISCOVERED by Linguamatics and unknown to Pharma and to Insurers, entity relations between:

Gene-Disease
Gene-Drug
Disease-Drug

These results were jointly presented to a Healthcare Insurer, SLC, UT on 7/13/2021, forthcoming meeting in 9/2021.

LPBI and BurstIQ are architecting NOW the first Natural Language Processing – Blockchain Information Technology infrastructure in existence, This statement is TRUE.

Updated on 7/28/2021:Fluree Flur.ee, the Web3 Data Platform Open source semantic graph database & LeadSemantics.com presented their solution for NLP and Blockchain on 7/28/2021. Erich G. was lured as Chief architect for LPBI’s Mission #2: NLP & Blockchain
Linguamatics, the leader in NLP did not hear of Blockchain and BurstIQ did not have a request for NLP – LPBI PUT THESE TWO TECHNOLOGIES AND PARTIES TOGETHER

See IMAGES SOURCE: BurstIQ image for LPBI

https://pharmaceuticalintelligence.com/2021/03/02/2-0-lpbi-is-a-very-unique-organization/

On 7/19/2021 – LPBI had launched LPBI India for Synthetic Biology Software for Drug Discovery targeting Galectins – Collaboration with Dr. Raphael Nir, President and CSO, SBH Sciences, Inc., Natick, MA
On 7/25/2021 – LPBI announced that it will have the NEWLY to be published BioMed e-Books As Mission #3:
A NEW Publishing GENRE of SCIENTIFIC BOOKS

o Bi-Lingual electronic Table Of Contents (eTOCs), English & Spanish with Montero Language Services, Madrid as the Translator of eighteen Books’ Cover Pages and the 18 books electronic Table of Contents.

o The Content promotion in the Spanish speaking Countries with GTO, Madrid as AD Agency.

o NLPs results of Medical Text Analysis with domain knowledge expert Interpretations in Foreign Languages and in Audio: in Spanish and in other languages, forthcoming

o Original English Book – Only Editorials (Preface, Introductions, Summaries and Epilogue) because the Bi-Lingual part has the eTOCs of the e-Book

o This is a new genre and a new architecture of 18 MULTIMEDIA SCIENTIFIC e-Books with (a) NLP results of the Medical Text analysis with machine learning, (b) Expert Interpretation of the Visualization Results. Bi-Lingual Podcasts: (c) eTOCs and (d) Bi-Lingual Expert Interpretation in English and Spanish Text and audio Podcasts, and (e) Books’ Editorials in English Audio Podcast

Content promotion proposal by GTO, Madrid

See IMAGES SOURCE: Rendition by GTO, Madrid of BurstIQ Image, above

2.0 LPBI is a Very Unique Organization

9. The Content Monetization effort includes the Price List for LPBI 1.0 digital products and of LPBI 2.0 – NLP Products

Under development

IP Valuation Model per IP asset class is needed to be compared with Master_Financials and to supplement it
Pricing Model and Product Mix Models for the digital products to be generated by the process of Text Analysis with NLP are using a Product Price List already developed.
The scenarios for a Probabilistic Product Mix for the B2B sector are work-in-progress. Scenarios of Product Mix for $500,000 B2B engagements with NLP scaling up with NLP Alliances. The Alliances are the Labor component and LPBI represent Materials (Content) as 25% of the contract price, on top of total, to be paid by the B2B customer as materials in use for the engagement.
B2C Customers on Blockchain will use the Price List for all Digital Products of LPBI 1.0 and LPBI 2.0 – Pay per Use

10. LPBI Group runs FIVE ACADEMIC INTERNSHIPS as Certificate Programs: a One Year long or a One Semester long: Volunteer base offering Verifiable Certificates, as described in https://pharmaceuticalintelligence.com/certificate-1-year/